Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands-Reference-Cited by-同舟云学术

Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands

Published:2008-10 Issue:46 Volume:26 Page:5883-5887
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

David Silke,Vermeer-de Bondt Patricia E.,van der Maas Nicoline A.T.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference22 articles.

1. Gezondheidsraad. Vaccinatie tegen Kinkhoest. 2004; publicatienr 2004/04:1–117.

2. Vaccinatie van zuigelingen tegen pneumokokkeninfecties. Gezondheidsraad 2005.

3. Vermeer-de Bondt PE, Dzaferagic A, Phaff TAJ, Wesselo C, Maas van der NAT. Adverse Events Following Immunisation under the National Vaccination Programme of The Netherlands, number 11. Reports in 2004. Bilthoven, The Netherlands: National Institute for public Health and the Environment, 2005; 240071002. http://www.rivm.nl/bibliotheek/rapporten/240071002.html.

4. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine;Gustafsson;N Engl J Med,1996

5. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine Ad Hoc Group for the Study of Pertussis Vaccines;Olin;Lancet,1997

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of awareness of mother about proper management of vaccine related problem;International Journal of Pharmacy and Infections Therapy;2023-10-20

2. A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis;Frontiers in Immunology;2023-04-27

3. Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy;Vaccines;2022-04-28

4. Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China;Human Vaccines & Immunotherapeutics;2022-01-31

5. More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands;The Lancet Regional Health - Europe;2021-11